» Articles » PMID: 37516746

An IPSC-derived Astrocyte Model of Fragile X Syndrome Exhibits Dysregulated Cholesterol Homeostasis

Overview
Journal Commun Biol
Specialty Biology
Date 2023 Jul 29
PMID 37516746
Authors
Affiliations
Soon will be listed here.
Abstract

Cholesterol is an essential membrane structural component and steroid hormone precursor, and is involved in numerous signaling processes. Astrocytes regulate brain cholesterol homeostasis and they supply cholesterol to the needs of neurons. ATP-binding cassette transporter A1 (ABCA1) is the main cholesterol efflux transporter in astrocytes. Here we show dysregulated cholesterol homeostasis in astrocytes generated from human induced pluripotent stem cells (iPSCs) derived from males with fragile X syndrome (FXS), which is the most common cause of inherited intellectual disability. ABCA1 levels are reduced in FXS human and mouse astrocytes when compared with controls. Accumulation of cholesterol associates with increased desmosterol and polyunsaturated phospholipids in the lipidome of FXS mouse astrocytes. Abnormal astrocytic responses to cytokine exposure together with altered anti-inflammatory and cytokine profiles of human FXS astrocyte secretome suggest contribution of inflammatory factors to altered cholesterol homeostasis. Our results demonstrate changes of astrocytic lipid metabolism, which can critically regulate membrane properties and affect cholesterol transport in FXS astrocytes, providing target for therapy in FXS.

Citing Articles

Neuron-Astrocyte Interactions: A Human Perspective.

Pio T, Hill E, Kebede N, Andersen J, Sloan S Adv Neurobiol. 2024; 39:69-93.

PMID: 39190072 DOI: 10.1007/978-3-031-64839-7_4.


Suppression of astrocyte BMP signaling improves fragile X syndrome molecular signatures and functional deficits.

Deng J, Labarta-Bajo L, Brandebura A, Kahn S, Pinto A, Diedrich J bioRxiv. 2024; .

PMID: 38979341 PMC: 11230279. DOI: 10.1101/2024.06.19.599752.


Astrocytes in fragile X syndrome.

Talvio K, Castren M Front Cell Neurosci. 2024; 17:1322541.

PMID: 38259499 PMC: 10800791. DOI: 10.3389/fncel.2023.1322541.

References
1.
Song Y, Liu J, Zhao K, Gao L, Zhao J . Cholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseases. Cell Metab. 2021; 33(10):1911-1925. DOI: 10.1016/j.cmet.2021.09.001. View

2.
Dunn W, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N . Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011; 6(7):1060-83. DOI: 10.1038/nprot.2011.335. View

3.
Spann N, Garmire L, McDonald J, Myers D, Milne S, Shibata N . Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell. 2012; 151(1):138-52. PMC: 3464914. DOI: 10.1016/j.cell.2012.06.054. View

4.
Mira E, Leon B, Barber D, Jimenez-Baranda S, Goya I, Almonacid L . Statins induce regulatory T cell recruitment via a CCL1 dependent pathway. J Immunol. 2008; 181(5):3524-34. DOI: 10.4049/jimmunol.181.5.3524. View

5.
Berry-Kravis E, Levin R, Shah H, Mathur S, Darnell J, Ouyang B . Cholesterol levels in fragile X syndrome. Am J Med Genet A. 2014; 167A(2):379-84. PMC: 5436717. DOI: 10.1002/ajmg.a.36850. View